Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$38.25
-$0.74 (-1.90%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 7.5M | n/a | n/a | 9.43M | 18.44M | 32.17M |
Cost of Revenue | 2.54M | 2.56M | 167.51M | n/a | n/a | n/a |
Gross Profit | 4.96M | -2.56M | -167.51M | 9.43M | 18.44M | 32.17M |
Operating Income | -373.07M | -279.3M | -214.05M | -129.14M | -78.99M | -31.3M |
Interest Income | 26.83M | 41.94M | 27.62M | 8.71M | 466K | 2.28M |
Pretax Income | -344.89M | -238.42M | -182.69M | -125.26M | -78.89M | -29.09M |
Net Income | -345.91M | -234.33M | -182.39M | -125.37M | -78.88M | -28.84M |
Selling & General & Admin | 79.63M | 68.9M | 46.54M | 32.81M | 21.97M | 12.94M |
Research & Development | 300.94M | 210.39M | 167.51M | 105.77M | 75.46M | 50.52M |
Other Expenses | -2.54M | -2.56M | -167.51M | n/a | n/a | n/a |
Operating Expenses | 378.03M | 276.74M | 46.54M | 138.58M | 97.43M | 63.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 484K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 380.57M | 279.3M | 214.05M | 138.58M | 97.43M | 63.47M |
Income Tax Expense | 1.02M | -4.09M | -292K | 118K | -6K | -257K |
Shares Outstanding (Basic) | 79.25M | 77.89M | 66.89M | 60.54M | 43.63M | 34.54M |
Shares Outstanding (Diluted) | 79.25M | 77.89M | 66.89M | 60.54M | 43.63M | 34.54M |
EPS (Basic) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 | -0.83 |
EPS (Diluted) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 | -0.83 |
EBITDA | -342.35M | -235.86M | -210.51M | -127.74M | -78.09M | -27.97M |
EBIT | -344.89M | -238.42M | -214.05M | -129.14M | -78.99M | -28.61M |
Depreciation & Amortization | 2.54M | 2.56M | 3.54M | 1.41M | 906K | 644K |
Add to Watchlist
Select watchlists to add or remove XENE